MXCT
MaxCyte, Inc. · Healthcare
Casdin Partners Master Fund, L.P. sold $4.5M of MaxCyte, Inc.
10% owner
Sold$4,525,084
$6.15Price
735,786Shares
−7%Stake
What MXCT did after the filing
- The stock from Wed, Oct 5 close, $7.29
- −8.1%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Nov 16 close.
Traded Mon, Oct 3. Filed Wed, Oct 5, 12:24 PM ET, during the session. Returns use the Oct 5 close and the Nov 16 close. Not investment advice.